CompoAtlas

Filmocid Process Matin

Food supplement declared in France, decision dated 22 October 2026

Filmocid Process Matin, from LAB. O2&VIE SAS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Andrographis paniculata 300 mg per day, Styphnolobium japonicum 107 mg per day, Reynoutria japonica 31 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LAB. O2&VIE SAS
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
Prendre 2 gélules par jour
Intended populations
General population
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking anticoagulants, Taking diabetes medication, Prolonged use
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 379995, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Andrographis paniculata (Burm. f.) NeesParties aériennesExtrait sec hydroalcoolique300 mg
Styphnolobium japonicum (L.) SchottFeuilleExtrait sec hydroalcoolique107 mg
Reynoutria japonica Houtt.RacineExtrait sec hydroalcoolique31 mg

Additives

E464

Other ingredients

amidon de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas utiliser en cas de grossesse. Déconseillé aux femmes allaitantes et aux enfants. Pour les personnes sous traitement antidiabétique ou anticoagulant, ne pas consommer le produit sans avoir pris l'avis au préalable d'un professionnel de santé. L'usage prolongé est déconseillé.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Filmocid Process Matin: composition and regulation”, https://compoatlas.com/en/supplements/products/379995-filmocid-process-matin, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line